secwatch.observer — SEC 8-K summary
======================================

Issuer:     Coherus Oncology, Inc. (CHRS)
CIK:        0001512762
Form:       8-K
Filed at:   2025-06-13T23:59:59+00:00
Accession:  0001104659-25-059351
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Coherus Oncology annual meeting results: all director nominees elected, say-on-pay and ESPP amendment approved
--------------------------------------------------------------------------------

- Stockholders elected Jill O'Donnell-Tormey, Michael Ryan, and Ali J. Satvat as Class II directors with 32.8M, 32.7M, and 27.8M votes for, respectively.
- Ratified Ernst & Young as independent auditor for FY 2025 with 74.5M votes for, 777K against, 306K abstain.
- Advisory say-on-pay resolution approved with 19.2M for, 16.2M against, 3.6M abstain; broker non-votes 36.7M.
- Amendment to 2014 Employee Stock Purchase Plan approved with 27.7M for, 7.6M against, 3.6M abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1512762/000110465925059351/0001104659-25-059351-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1512762/000110465925059351/tm2517926d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-059351

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer